Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Stroke

Limited impact of omega-3 fatty acids in patients with multiple cardiovascular risk factors
Philip Calder

BMJ Evidence-Based Medicine Feb 2014, 19 (1) 18; DOI: 10.1136/eb-2013-101440
For patients who underwent elective non-cardiac surgery, a history of stroke is associated with an increased risk of major adverse cardiovascular events and death, particularly if time elapsed between stroke and surgery is less than 9 months
Murat Biteker

BMJ Evidence-Based Medicine Feb 2015, 20 (1) 26; DOI: 10.1136/ebmed-2014-110085
Prophylactic dose fondaparinux for 6 weeks in superficial thrombophlebitis of the legs reduces the risk for symptomatic thromboembolic complications
Maria T DeSancho, Stephen M Pastores

BMJ Evidence-Based Medicine Feb 2013, 18 (1) 28-29; DOI: 10.1136/eb-2012-100755
Mendelian randomisation meta-analysis sheds doubt on protective associations between ‘moderate’ alcohol consumption and coronary heart disease
Tanya N Chikritzhs, Timothy S Naimi, Tim R Stockwell, Wenbin Liang

BMJ Evidence-Based Medicine Feb 2015, 20 (1) 38; DOI: 10.1136/ebmed-2014-110086
Conservative management for low-risk prostate cancer improves quality-adjusted life expectancy at lower cost compared with initial treatment
Laurence Klotz

BMJ Evidence-Based Medicine Feb 2014, 19 (1) 40; DOI: 10.1136/eb-2013-101481
Review: thrombolytic treatment does not reduce the risk of recurrent pulmonary embolism and death more than heparin
BMJ Evidence-Based Medicine Apr 2005, 10 (2) 41; DOI: 10.1136/ebm.10.2.41
Atorvastatin reduced major cardiovascular disease events in type 2 diabetes mellitus
BMJ Evidence-Based Medicine Apr 2005, 10 (2) 43; DOI: 10.1136/ebm.10.2.43
Isosorbide dinitrate plus hydralazine was effective for advanced heart failure in black patients
BMJ Evidence-Based Medicine Apr 2005, 10 (2) 44; DOI: 10.1136/ebm.10.2.44
An abnormal D-dimer test result indicated that anticoagulant therapy should be continued
BMJ Evidence-Based Medicine Apr 2007, 12 (2) 45; DOI: 10.1136/ebm.12.2.45
Review: statins reduce stroke but not stroke mortality
BMJ Evidence-Based Medicine Jun 2005, 10 (3) 73; DOI: 10.1136/ebm.10.3.73

Pages